The same effect was noticed after clopidogrel chronic use, where increased platelet aggregation, glycoprotein (GP)IIIb/IIIa activation, and higher P-selection expression were present in patients with T2DM vs. non-diabetic patients, considering patients with T2DM as non-responders [139]. Here, ART4 is linked to type 2 diabetes mellitus.